Summary & Overview
HCPCS J0613: Calcium Gluconate Injection, Critical Care 10 mg
HCPCS Level II code J0613 denotes a 10 mg injection of calcium gluconate intended for critical care use and is explicitly noted as not therapeutically equivalent to J0612. This designation matters nationally because calcium gluconate is a commonly used acute treatment in electrolyte disturbances and emergency settings; correct coding ensures appropriate clinical documentation and payer recognition for high-acuity drug administration. Key payers included in the coverage discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context for J0613, where it is typically administered, and why differentiating it from similar HCPCS codes matters for billing and claims processing. The publication summarizes benchmarking and coding guidance, highlights payer coverage patterns and common modifiers used with injectable drug codes, and outlines potential policy considerations that affect payment and medical necessity review. When specific data fields were not provided in the input, the text indicates "Data not available in the input." The focus is national in scope and aims to support administrators, coders, and clinicians in aligning documentation with this HCPCS Level II code for acute-care medication delivery.
Billing Code Overview
HCPCS Level II code J0613 describes an injection of calcium gluconate, identified as a product used in critical care settings. The code specifies a 10 mg unit and notes that this formulation is not therapeutically equivalent to J0612.
Service Type: Injectable medication (critical care)
Typical Site of Service: Hospital inpatient, emergency department, or other acute care settings where critical care medications are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient receiving J0613 is an adult or pediatric patient presenting in the emergency department, inpatient unit, or critical care setting with documented hypocalcemia, symptomatic hypocalcemia (perioral numbness, tetany, seizures), or as part of advanced life support when ionized calcium is low or suspected. The medication J0613 (calcium gluconate injection) is administered intravenously by an emergency physician, hospitalist, intensivist, or licensed advanced practice clinician. Clinical workflow: assessment of symptoms and review of serum calcium (total and/or ionized) and relevant electrolytes; establishment of IV access; preparation of the correct concentration and dose (packaged as 10 mg unit per billing descriptor); verification of patient identity, allergies, and concurrent medications; administration as slow IV push or infusion per local protocol; monitoring of cardiac rhythm and vital signs during and after administration; documentation of dose, route, time, lot number, and clinical response in the medical record. Typical sites of service include the emergency department, inpatient ward, intensive care unit, and procedural areas where urgent correction of calcium is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
23 | Unusual Anesthesia | Use when general anesthesia is administered unusually for the service (rare for but applicable if given intraoperatively with unusual anesthesia). |